819 related articles for article (PubMed ID: 18063423)
1. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Wajda A; Blanchard JF
Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423
[TBL] [Abstract][Full Text] [Related]
2. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.
Bernstein CN; Blanchard JF; Houston DS; Wajda A
Thromb Haemost; 2001 Mar; 85(3):430-4. PubMed ID: 11307809
[TBL] [Abstract][Full Text] [Related]
3. Risk of arterial thrombotic events in inflammatory bowel disease.
Ha C; Magowan S; Accortt NA; Chen J; Stone CD
Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
[TBL] [Abstract][Full Text] [Related]
4. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Wajda A; Blanchard JF
Gastroenterology; 2005 Sep; 129(3):827-36. PubMed ID: 16143122
[TBL] [Abstract][Full Text] [Related]
5. The association between corticosteroid use and development of fractures among IBD patients in a population-based database.
Bernstein CN; Blanchard JF; Metge C; Yogendran M
Am J Gastroenterol; 2003 Aug; 98(8):1797-801. PubMed ID: 12907335
[TBL] [Abstract][Full Text] [Related]
6. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
[TBL] [Abstract][Full Text] [Related]
7. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
Metge CJ; Blanchard JF; Peterson S; Bernstein CN
Am J Gastroenterol; 2001 Dec; 96(12):3348-55. PubMed ID: 11774948
[TBL] [Abstract][Full Text] [Related]
8. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
Kappelman MD; Horvath-Puho E; Sandler RS; Rubin DT; Ullman TA; Pedersen L; Baron JA; Sørensen HT
Gut; 2011 Jul; 60(7):937-43. PubMed ID: 21339206
[TBL] [Abstract][Full Text] [Related]
9. Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
Gupta G; Gelfand JM; Lewis JD
Gastroenterology; 2005 Sep; 129(3):819-26. PubMed ID: 16143121
[TBL] [Abstract][Full Text] [Related]
10. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease.
García Rodríguez LA; Ruigómez A; Panés J
Gastroenterology; 2006 May; 130(6):1588-94. PubMed ID: 16697722
[TBL] [Abstract][Full Text] [Related]
11. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
[TBL] [Abstract][Full Text] [Related]
14. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.
Gradel KO; Nielsen HL; Schønheyder HC; Ejlertsen T; Kristensen B; Nielsen H
Gastroenterology; 2009 Aug; 137(2):495-501. PubMed ID: 19361507
[TBL] [Abstract][Full Text] [Related]
15. The relationship between inflammatory bowel disease and socioeconomic variables.
Bernstein CN; Kraut A; Blanchard JF; Rawsthorne P; Yu N; Walld R
Am J Gastroenterol; 2001 Jul; 96(7):2117-25. PubMed ID: 11467642
[TBL] [Abstract][Full Text] [Related]
16. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study.
Bernstein CN; Nugent Z; Longobardi T; Blanchard JF
Am J Gastroenterol; 2009 Nov; 104(11):2774-8. PubMed ID: 19623167
[TBL] [Abstract][Full Text] [Related]
17. Health care resource utilization in inflammatory bowel disease.
Longobardi T; Bernstein CN
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):731-43. PubMed ID: 16631415
[TBL] [Abstract][Full Text] [Related]
18. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P;
Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel disease in relation to contact allergy: a patient-based study.
Engkilde K; Menné T; Johansen JD
Scand J Gastroenterol; 2007 May; 42(5):572-6. PubMed ID: 17454877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]